OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Cell-Based Platform for Antigen Testing and Its Application for SARS-CoV-2 Infection
Marvin A. Ssemadaali, Sherri L. Newmyer, Harikrishnan Radhakrishnan, et al.
Microbiology Spectrum (2022) Vol. 10, Iss. 4
Open Access | Times Cited: 7
Marvin A. Ssemadaali, Sherri L. Newmyer, Harikrishnan Radhakrishnan, et al.
Microbiology Spectrum (2022) Vol. 10, Iss. 4
Open Access | Times Cited: 7
Showing 7 citing articles:
Antiviral T-cell Biofactory platform for SARS-CoV-2
Marvin A. Ssemadaali, Sherri L. Newmyer, Harikrishnan Radhakrishnan, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 6
Marvin A. Ssemadaali, Sherri L. Newmyer, Harikrishnan Radhakrishnan, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 6
Genetically engineered pair of cells for serological testing and its application for SARS‐CoV ‐2
Marvin A. Ssemadaali, Juan Arredondo, Elise Buser, et al.
Bioengineering & Translational Medicine (2023) Vol. 8, Iss. 3
Open Access | Times Cited: 3
Marvin A. Ssemadaali, Juan Arredondo, Elise Buser, et al.
Bioengineering & Translational Medicine (2023) Vol. 8, Iss. 3
Open Access | Times Cited: 3
Electrically regulated cell‐based intervention for viral infections
Sherri L. Newmyer, Marvin A. Ssemadaali, Harikrishnan Radhakrishnan, et al.
Bioengineering & Translational Medicine (2022) Vol. 8, Iss. 2
Open Access | Times Cited: 4
Sherri L. Newmyer, Marvin A. Ssemadaali, Harikrishnan Radhakrishnan, et al.
Bioengineering & Translational Medicine (2022) Vol. 8, Iss. 2
Open Access | Times Cited: 4
Engineered CD4 T cells for in vivo delivery of therapeutic proteins
Harikrishnan Radhakrishnan, Sherri L. Newmyer, Harold S. Javitz, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 40
Open Access
Harikrishnan Radhakrishnan, Sherri L. Newmyer, Harold S. Javitz, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 40
Open Access
Primary T‐cell‐based delivery platform for in vivo synthesis of engineered proteins
Harikrishnan Radhakrishnan, Sherri L. Newmyer, Marvin A. Ssemadaali, et al.
Bioengineering & Translational Medicine (2023)
Open Access | Times Cited: 1
Harikrishnan Radhakrishnan, Sherri L. Newmyer, Marvin A. Ssemadaali, et al.
Bioengineering & Translational Medicine (2023)
Open Access | Times Cited: 1
A cardiotoxicity-eliminated ACE2 variant as a pan-inhibitor against coronavirus cell invasion
Han Feng, Linpu Yang, Hang Yang, et al.
Molecular Therapy (2023) Vol. 32, Iss. 1, pp. 218-226
Closed Access | Times Cited: 1
Han Feng, Linpu Yang, Hang Yang, et al.
Molecular Therapy (2023) Vol. 32, Iss. 1, pp. 218-226
Closed Access | Times Cited: 1
